Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Edlin

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Journal of Virology|December 13, 2003
Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposureRose Tsui, Belinda L Herring, Jason D Barbour, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 7, 2003
Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay AreaKaren H Seal, Moher Downing, Alex H Kral, et al.
The Journal of Infectious Diseases|March 28, 2003
Seroprevalence of human herpesvirus 8 among injection drug users in San FranciscoJonnae Atkinson, Brian R Edlin, Eric A Engels, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoproteinP Wilfredo Canchis, Stevan A Gonzalez, M Isabel Fiel, et al.
The Journal of Infectious Diseases|October 21, 2011
IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive associationFatma M Shebl, Ruth M Pfeiffer, Dianna Buckett, et al.
BMC Infectious Diseases|December 12, 2007
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionPeter Bacchetti, Phyllis C Tien, Eric C Seaberg, et al.
Hepatology (Baltimore, Md.)|July 28, 2007
Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000Fan-Chen Tseng, Thomas R O'Brien, Mingdong Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2005
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug usersBrian R Edlin, Thomas F Kresina, Daniel B Raymond, et al.
Journal of Medical Virology|March 26, 2004
PCR-probe capture hybridization assay and statistical model for SEN virus prevalence estimationYasuhito Tanaka, Ruth Pfeiffer, Anthony E T Yeo, et al.
Plos One|May 26, 2017
Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for preventionBenjamin Eckhardt, Emily R Winkelstein, Marla A Shu, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Journal of Virology|December 13, 2003
Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposureRose Tsui, Belinda L Herring, Jason D Barbour, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 7, 2003
Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay AreaKaren H Seal, Moher Downing, Alex H Kral, et al.
The Journal of Infectious Diseases|March 28, 2003
Seroprevalence of human herpesvirus 8 among injection drug users in San FranciscoJonnae Atkinson, Brian R Edlin, Eric A Engels, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoproteinP Wilfredo Canchis, Stevan A Gonzalez, M Isabel Fiel, et al.
The Journal of Infectious Diseases|October 21, 2011
IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive associationFatma M Shebl, Ruth M Pfeiffer, Dianna Buckett, et al.
BMC Infectious Diseases|December 12, 2007
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionPeter Bacchetti, Phyllis C Tien, Eric C Seaberg, et al.
Hepatology (Baltimore, Md.)|July 28, 2007
Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000Fan-Chen Tseng, Thomas R O'Brien, Mingdong Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2005
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug usersBrian R Edlin, Thomas F Kresina, Daniel B Raymond, et al.
Journal of Medical Virology|March 26, 2004
PCR-probe capture hybridization assay and statistical model for SEN virus prevalence estimationYasuhito Tanaka, Ruth Pfeiffer, Anthony E T Yeo, et al.
Plos One|May 26, 2017
Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for preventionBenjamin Eckhardt, Emily R Winkelstein, Marla A Shu, et al.
Pageof 8